The inclusion of the 3D imaging technology PlatinumTomo in the Mammomat B.brilliant device reportedly enables clinicians to obtain 50-degree 3D images in less than five seconds.
Offering a variety of new features for improved efficiency and enhanced 3D breast imaging, the mammography platform Mammomat B.brilliant has garnered an expanded approval from the Food and Drug Administration (FDA).
Building upon the 50-degree wide-angle technology of its existing 3D mammography systems, Siemens Healthineers says the expanded approval for the device includes PlatinumTomo, which reduces blurring that commonly occurs with 3D imaging and allows one to obtain 50-degree 3D images in less than five seconds.
New features with the Mammomat B.brilliant platform include PlatinumTomo, which enables five-second acquisition of 50-degree 3D images, and UltraHD technology, which reduces metal artifacts and provides enhanced visualization of calcifications, according to Siemens Healthineers, the manufacturer of the device. (Image courtesy of Siemens Healthineers.)
Other new features with the Mammomat B.brilliant platform include a new X-ray tube, which includes adaptation of the flying focal spot technology from the company’s computed tomography (CT) scanners, according to Siemens Healthineers, the manufacturer of the Mammomat B.brilliant Device.
The company pointed out that the expanded approval also includes UltraHD technology for image reconstruction that facilitates enhanced calcification visualization, reduced metal artifacts and the availability of synthetic 2D images without exposing patients to additional radiation.
“This revolutionary system not only provides health-care institutions with significantly improved diagnostic capabilities but also addresses the critical need for patient and technologist comfort in breast cancer screening,” added Niral Patel, the vice president of X-ray products at Siemens Healthineers North America.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
August 2nd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
August 2nd 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.